r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AL

ADAR1 Capital Management, LLC

Insider · 10% owner · TENX

ADAR1 Capital Management, LLC files insider transactions with the SEC as a 10% owner of Tenax Therapeutics (TENX). We hold 22 disclosed purchases and sales filed since 12 August 2024, 13 of them in the last 90 days.

  • Files forTENX
  • Disclosed buys and sells22 in all, 13 in the last 90 days
  • Last disclosure8 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 August 2026 — 3 September 202610% owner · Tenax Therapeutics (TENX)7 Form 4 lines · source: SEC Form 4
  • Filed 27 July 2026 — 31 July 202610% owner · NextCure (NXTC)13 Form 4 lines · source: SEC Form 4
  • Filed 19 May 2026 — 15 July 202610% owner · InMed Pharmaceuticals (INM)4 Form 4 lines · source: SEC Form 4
  • Filed 4 May 2026 — 19 May 202610% owner · Rallybio (RLYB)14 Form 4 lines · source: SEC Form 4
  • Filed 16 May 2025 — 16 May 202510% owner · Keros Therapeutics (KROS)3 Form 4 lines · source: SEC Form 4
  • Filed 9 August 2024 — 12 August 202410% owner · Pieris Pharmaceuticals (PIRS)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

44 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.